新2备用网址（www.hg108.vip）是一个开放新2网址即时比分、新2网址代理最新登录线路、新2网址会员最新登录线路、新2网址代理APP下载、新2网址会员APP下载、新2网址线路APP下载、新2网址电脑版下载、新2网址手机版下载的新2新现金网平台。新2网址登录线路最新、新2皇冠网址更新最快,皇冠体育APP开放皇冠会员注册、皇冠代理开户等业务。

KUALA LUMPUR: Ta Win Holdings Bhd has proposed to dispose of its entire 32.5% stake or 3.897 million ordinary shares in Royce Pharma Manufacturing Sdn Bhd for RM20.85mil.In a Bursa filing, the copper wires and rods manufacturer said its wholly-owned subsidiary Ta Win Copper Biohealth Sdn Bhd has entered into a share sale agreement with Poly Laboratories Sdn Bhd and Jelita Serbaneka Sdn Bhd for the proposed disposal.Upon completion of the proposed disposal, Ta Win continues to account for investment in Royce Pharma as an associate company via its 1.8 million preference shares.“The proposed disposal represents an opportunity for Ta Win to dispose of its healthcare and pharmaceutical business segment for a pricing term which is no less than favourable (i.e. the disposal consideration is no less than its original cost of investment) in the current challenging operating environment,” it said.It added that the proposed disposal is deemed as a strategic reorganisation plan to better realign the vision of Ta Win to become a prominent integrated one-stop copper-solutions provider in the South East Asian region.